Analysts warn that the companies should fight temptations to move away from electrification and lean further into gas-powered ...

The Congressional Review Act can axe costly Biden rules.

CVR Energy stock has significantly underperformed, with a -38% return in 2024. Check out why I maintain my Sell rating on CVI ...

Turmoil at the agency could harm not only consumers but also small state-chartered banks, as their bigger rivals gain ...

The financial sector continues to face new rules and government expectations as part of the broader effort to aid the green ...

Recent periods of financial stress and the proliferation of risks across the financial system are fueling the development of ...

"The biggest shift is taking place in terms of how the federal government views privacy and data-related issues, including a ...

This paper adds to existing evidence about the cost of increasing regulation in foregone economic growth and highlights the issue for policymakers. The effects of growing regulation on the pace of ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics. Generation of a stable, high-performance, monoclonal cell line producing a ...

Acting Chairman Caroline Pham, appointed by President Donald Trump, is at the forefront of this initiative, which comes amid ongoing legal and regulatory challenges that prediction markets have ...

Moody’s notes that while these arrangements can enhance capital efficiency, they also introduce additional counterparty risk and regulatory oversight challenges. US insurance regulators have ...